Hepatoprotective effects of caffeic acid in D-galactose-induced aging in mice: investigation of antioxidant mechanisms

Document Type : Original Article

Authors

1 School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran

2 Department of Anatomical Sciences, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran

Abstract

Background and Objective: The liver is a complex metabolic organ that maintains body homeostasis. Oxidative stress caused by aging is an important risk factor in the development of chronic liver diseases. This study aimed to investigate the effect of caffeic acid on oxidative damage caused by aging in mice.
Materials and Methods: In this experimental study, 40 male mice were randomly divided into 5 groups (n=8): 1) control (Con); 2) Sham; 3) caffeic acid (CA), 4) aging (Ag), and 5) aging + caffeic acid (Ag + CA). The aging model was induced through daily intraperitoneal (i.p.) injections of D-galactose (300 mg/kg) for 6 weeks. Caffeic acid (60 mg/kg, i.p.) was injected daily for 6 weeks. The mice were anesthetized 24 hours after the last injection and the liver was removed immediately. Then, oxidative stress factors (malondialdehyde (MDA), superoxide dismutase (SOD), glutathione peroxidase (GPx) and total antioxidant capacity (TAC)) were investigated by One way ANOVA and Tukey.
Results: The results showed that D-galactose-induced aging significantly increases the level of MDA and also decreases the level of SOD, GPx, and TAC in the liver compared to the control and sham groups (P<0.05). Treatment with caffeic acid in the Ag + CA group significantly decreased MDA levels and improved the activity of SOD, GPx, and TAC (P<0.05).
Conclusion: The results showed that caffeic acid reduces lipid peroxidation and improves the liver antioxidant enzyme function.

Keywords

Main Subjects

References

  1. Azman KF, Safdar A, Zakaria R. D-galactose-induced liver aging model: Its underlying mechanisms and potential therapeutic interventions. Experimental Gerontology. 2021;150:111372.
  2. Bahrami M, Sobhi P, Mahdizadeh F, Rahimi S, Khodaei L, Ojarudi M, et al. Examining Effects of Metformin and Coenzyme Q10 on Doxorubicin-Induced Oxidative Hepatotoxicity in Rats. Journal of Mazandaran University of Medical Sciences. 2024;34(233):1-14.
  3. Gao J, Yu Z, Jing S, Jiang W, Liu C, Yu C, et al. Protective effect of Anwulignan against D-galactose-induced hepatic injury through activating p38 MAPK–Nrf2–HO-1 pathway in mice. Clinical Interventions in Aging. 2018:1859-69.
  4. Habieb M, Mohamed M, El Gamal D, Hawas A, Mohamed T. Anti-aging effect of DL-β-hydroxybutyrate against hepatic cellular senescence induced by D-galactose or γ-irradiation via autophagic flux stimulation in male rats. Archives of Gerontology and Geriatrics. 2021;92:104288.
  5. Khoshdel F, Golmohammadi MG, Dost MJ, Najafzade N, Salimnejad R. Impact of caffeic acid on the testicular damages in D-galactose-induced aging model in mice. Iranian Journal of Basic Medical Sciences. 2022;25(10):1190-95.
  6. Harman D. Free radical theory of aging: the “free radical” Age. 1984;7(4):111-31.
  7. Saleh DO, Mansour DF, Hashad IM, Bakeer RM. Effects of sulforaphane on D-galactose-induced liver aging in rats: Role of keap-1/nrf-2 pathway. European Journal of Pharmacology. 2019;855:40-49.
  8. Casas-Grajales S, Muriel P. Antioxidants in liver health. World Journal of Gastrointestinal Pharmacology and Therapeutics. 2015;6(3):59-64.
  9. Farzaei MH, Zobeiri M, Parvizi F, El-Senduny FF, Marmouzi I, Coy-Barrera E, et al. Curcumin in liver diseases: a systematic review of the cellular mechanisms of oxidative stress and clinical perspective. Nutrients. 2018;10(7):855-61.
  10. Gillessen A, Schmidt HH-J. Silymarin as supportive treatment in liver diseases: a narrative review. Advances in Therapy. 2020;37(4):1279-01.
  11. Khordad E, Alipour F, Pourabbas M, Mansouri S, Salimnejad R. Hepatoprotective impact of ghrelin against cyclophosphamide-induced toxicity in the male mice. Drug Research. 2021;71(07):407-12.
  12. Magnani C, Isaac VLB, Correa MA, Salgado HRN. Caffeic acid: a review of its potential use in medications and cosmetics. Analytical Methods. 2014;6(10):3203-10.
  13. Kim HM, Kim Y, Lee ES, Huh JH, Chung CH. Caffeic acid ameliorates hepatic steatosis and reduces ER stress in high fat diet–induced obese mice by regulating autophagy. Nutrition. 2018;55:63-70.
  14. Pari L, Prasath A. Efficacy of caffeic acid in preventing nickel induced oxidative damage in liver of rats. Chemico-Biological Interactions. 2008;173(2):77-83.
  15. Dey S, Bindu S, Goyal M, Pal C, Alam A, Iqbal MS, et al. Impact of intravascular hemolysis in malaria on liver dysfunction: involvement of hepatic free heme overload, NF-κB activation, and neutrophil infiltration. Journal of Biological Chemistry. 2012;287(32):26630-46.
  16. De Leon JAD, Borges CR. Evaluation of oxidative stress in biological samples using the thiobarbituric acid reactive substances assay. Journal of Visualized Experiments. 2020;12(159):10.3791/61122.
  17. Munteanu IG, Apetrei C. Analytical methods used in determining antioxidant activity: A review. International Journal of Molecular Sciences. 2021;22(7):3380.
  18. El-Far AH, Elghaity MM, Mohamed SA, Noreldin AE, Elewa YH, Al Jaouni SK, et al. Diosgenin alleviates D-galactose-induced oxidative stress in rats’ brain and liver targeting aging and apoptotic marker genes. Frontiers in Molecular Biosciences. 2024;11:1303379.
  19. Omidkhoda SF, Mehri S, Heidari S, Hosseinzadeh H. Protective effects of crocin against hepatic damages in D-galactose aging model in rats. Iranian Journal of Pharmaceutical Research. 2020;19(3):440-45.
  20. Kazemi S, Asgary S, Moshtaghian J, Rafieian M, Adelnia A, Shamsi F. Liver-protective effects of hydroalcoholic extract of allium hirtifolium boiss. In rats with alloxan-induced diabetes mellitus. ARYA Atherosclerosis. 2010;6(1):11-15.
  21. Firuzi O, Miri R, Tavakkoli M, Saso L. Antioxidant therapy: current status and future prospects. Current medicinal chemistry. 2011;18(25):3871-88.
  22. Zhang J, Ouyang H, Gu X, Dong S, Lu B, Huang Z, et al. Caffeic acid ameliorates metabolic dysfunction-associated steatotic liver disease via alleviating oxidative damage and lipid accumulation in hepatocytes through activating Nrf2 via targeting Keap1. Free Radical Biology and Medicine. 2024; 8(224):352-365.
  23. Li M, Wang X-F, Shi J-J, Li Y-P, Yang N, Zhai S, et al. Caffeic acid phenethyl ester inhibits liver fibrosis in rats. World Journal of Gastroenterology. 2015;21(13):3893.
  24. Pavlíková N. Caffeic acid and diseases—Mechanisms of action. International Journal of Molecular Sciences. 2022;24(1):588.
Daneshvar Medicine
Volume 32, Issue 5 - Serial Number 174
January and February 2025
Pages 1-10

Files

Share

How to cite

Statistics